InMed Pharmaceuticals (MWG.F) Q4 2024 Earnings

15NovConfirmed
Sep 21
Feb 23
Q1 2023
Q4 2024
-2.57
-1.83
-1.08
-0.34

Details

Expected EPS
N/A
Actual EPS
-2.5701910999999997
Surprise EPS
-2.57
Surprise Percent
+∞%

Description

InMed Pharmaceuticals (MWG.F) has reported earnings of -2.5701910999999997 per share for Q4 2024.

0 Comments

Share your thoughts